Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

S.A.J. Timmer, T. Germans, W.P Brouwer, J.M. Lubberink, J. van der Velden, A.A.M. Wilde, I. Christiaans, A.A. Lammertsma, P. Knaapen, A.C. van Rossum

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1283-1289
JournalEuropean Journal of Heart Failure
Issue number12
Publication statusPublished - 2011

Cite this